A leader in research tools and clinical diagnostic development asked us to evaluate the opportunity for an ultrasensitive detection platform in methylation analysis
DeciBio
charactered the current and future methylation analysis landscape, defining primary use cases and users as well as key pain points with current technologies
prioritized application areas for the client’s specific detection platform based on the platform’s unique value proposition and technical specifications
built a 5-year model to project the market size and client’s market share in the methylation analysis market
Research Tools
Application Identification
Target Identification